174 related articles for article (PubMed ID: 10775848)
21. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
[TBL] [Abstract][Full Text] [Related]
22. Induced expression of p16 and p21 proteins in UVB-irradiated human epidermis and cultured keratinocytes.
Ahmed NU; Ueda M; Ichihashi M
J Dermatol Sci; 1999 Apr; 19(3):175-81. PubMed ID: 10215189
[TBL] [Abstract][Full Text] [Related]
23. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha.
Funasaka Y; Chakraborty AK; Hayashi Y; Komoto M; Ohashi A; Nagahama M; Inoue Y; Pawelek J; Ichihashi M
Br J Dermatol; 1998 Aug; 139(2):216-24. PubMed ID: 9767234
[TBL] [Abstract][Full Text] [Related]
24. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions.
Keller-Melchior R; Schmidt R; Piepkorn M
J Invest Dermatol; 1998 Jun; 110(6):932-8. PubMed ID: 9620301
[TBL] [Abstract][Full Text] [Related]
25. Genes involved in melanoma: an overview of INK4a and other loci.
Castellano M; Parmiani G
Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
Wang Y; Becker D
Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
[TBL] [Abstract][Full Text] [Related]
27. p16 is a major inactivation target in hepatocellular carcinoma.
Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
[TBL] [Abstract][Full Text] [Related]
28. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma.
Funk JO; Schiller PI; Barrett MT; Wong DJ; Kind P; Sander CA
J Cutan Pathol; 1998 Jul; 25(6):291-6. PubMed ID: 9694617
[TBL] [Abstract][Full Text] [Related]
29. Ultraviolet A and B differently induce intracellular protein expression in human skin melanocytes--a speculation of separate pathways in initiation of melanoma.
Zhang H; Rosdahl I
Carcinogenesis; 2003 Dec; 24(12):1929-34. PubMed ID: 14514652
[TBL] [Abstract][Full Text] [Related]
30. Responses of the 27-kDa heat shock protein to UVB irradiation in human epidermal melanocytes.
Shi B; Grahn JC; Reilly DA; Dizon TC; Isseroff RR
Exp Dermatol; 2008 Feb; 17(2):108-14. PubMed ID: 18031542
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
32. Somatic p16(INK4a) loss accelerates melanomagenesis.
Monahan KB; Rozenberg GI; Krishnamurthy J; Johnson SM; Liu W; Bradford MK; Horner J; Depinho RA; Sharpless NE
Oncogene; 2010 Oct; 29(43):5809-17. PubMed ID: 20697345
[TBL] [Abstract][Full Text] [Related]
33. The p16(INK4A) tumor suppressor regulates cellular oxidative stress.
Jenkins NC; Liu T; Cassidy P; Leachman SA; Boucher KM; Goodson AG; Samadashwily G; Grossman D
Oncogene; 2011 Jan; 30(3):265-74. PubMed ID: 20838381
[TBL] [Abstract][Full Text] [Related]
34. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
35. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
[TBL] [Abstract][Full Text] [Related]
36. Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
McKenzie HA; Fung C; Becker TM; Irvine M; Mann GJ; Kefford RF; Rizos H
Hum Mutat; 2010 Jun; 31(6):692-701. PubMed ID: 20340136
[TBL] [Abstract][Full Text] [Related]
37. p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.
Sviderskaya EV; Gray-Schopfer VC; Hill SP; Smit NP; Evans-Whipp TJ; Bond J; Hill L; Bataille V; Peters G; Kipling D; Wynford-Thomas D; Bennett DC
J Natl Cancer Inst; 2003 May; 95(10):723-32. PubMed ID: 12759390
[TBL] [Abstract][Full Text] [Related]
38. [From gene to disease; from p16 to melanoma].
Gruis NA; Bergman W
Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
[TBL] [Abstract][Full Text] [Related]
39. Wavelength dependence of cellular responses in human melanocytes and melanoma cells following exposure to ultraviolet radiation.
Kowalczuk CI; Priestner MC; Pearson AJ; Saunders RD; Bouffler SD
Int J Radiat Biol; 2006 Nov; 82(11):781-92. PubMed ID: 17148262
[TBL] [Abstract][Full Text] [Related]
40. MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A.
Loercher AE; Tank EM; Delston RB; Harbour JW
J Cell Biol; 2005 Jan; 168(1):35-40. PubMed ID: 15623583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
